Related Experiment Video
Updated: Aug 14, 2026

Myocardial Infarction and Functional Outcome Assessment in Pigs
Published on: April 25, 2014
Primary percutaneous coronary intervention versus thrombolytic treatment: long term follow up according to infarct
J P S Henriques1, F Zijlstra, A W J van 't Hof
1Department of Cardiology, Isala Klinieken, locatie Weezenlanden, Zwolle, The Netherlands.
Insights
Primary angioplasty (PCI) significantly improves long-term survival for ST-elevation myocardial infarction (STEMI) patients, especially those with anterior STEMI. PCI offers additional survival benefits beyond the first year compared to thrombolysis.
Area of Science:
- Cardiology
- Interventional Cardiology
- Clinical Trials
Background:
- ST-elevation myocardial infarction (STEMI) is a critical condition requiring timely reperfusion therapy.
- Comparing primary percutaneous coronary intervention (PCI) with thrombolysis is essential for optimizing patient outcomes.
- Infarct location may influence the long-term effectiveness of reperfusion strategies.
Purpose of the Study:
- To evaluate the clinical significance of infarct location on long-term survival.
- To compare the efficacy of primary PCI versus thrombolysis in patients with acute STEMI.
- To assess the impact of infarct location on treatment outcomes in a randomized trial.
Main Methods:
- Retrospective longitudinal cohort analysis of prospectively entered data from the Zwolle trial.
- 395 patients with acute STEMI were randomly assigned to intravenous streptokinase or primary PCI.
- Survival and major adverse cardiac events (MACE) were analyzed according to infarct location and treatment over 8 years.
Main Results:
- Overall mortality was lower in the primary PCI group (42 deaths) compared to the streptokinase group (63 deaths).
- For anterior STEMI, primary PCI significantly reduced mortality compared to streptokinase (RR 2.7, p=0.004), with an NNT of 5 to prevent one death.
- In non-anterior STEMI, mortality did not differ, but primary PCI reduced MACE (RR 2.1, NNT of 4).
Conclusions:
- Primary PCI offers superior long-term survival for patients with anterior STEMI compared to streptokinase.
- Primary PCI provides an additional survival benefit beyond the first year, likely due to preserved left ventricular function.
- Infarct location is a critical factor influencing the long-term benefits of reperfusion therapy in STEMI.
Objectives:
To study the clinical significance of infarct location during long term follow up in a trial comparing thrombolysis with primary angioplasty.
Design:
Retrospective longitudinal cohort analysis of prospectively entered data.
Setting:
Patients with acute ST elevation myocardial infarction (STEMI) treated with primary percutaneous coronary intervention (PCI).
Patients:
In the Zwolle trial 395 patients with acute STEMI were randomly assigned to intravenous streptokinase or PCI.
Main Outcome Measures:
Survival according to infarct location and treatment after 8 (2) years of follow up.
Results:
105 patients died: 63 patients in the streptokinase group and 42 patients in the primary PCI group (relative risk (RR) 1.6, 95% confidence interval (CI) 1.0 to 2.6; p = 0.03). In patients with non-anterior STEMI there was no difference in mortality between streptokinase and PCI treated patients (RR 1.1, 95% CI 0.6 to 2.1; p = 0.68) but the streptokinase group had significantly more major adverse cardiac events (MACE) than the PCI group (RR 2.1, 95% CI 1.2 to 3.6). The number needed to treat to prevent one MACE was four. In patients with anterior STEMI, mortality was higher in the streptokinase group than in the PCI group (RR 2.7, 95% CI 1.4 to 5.5; p = 0.004). The number needed to treat to prevent one death was five. Kaplan-Meier analysis confirmed the benefits of primary angioplasty in the first year and showed additional benefit of PCI compared with streptokinase between 1-8 years after the acute event.
Conclusions:
Patients with anterior STEMI have better long term survival when treated with PCI than with streptokinase. In patients alive one year after the acute event, PCI confers a significant additional survival benefit, probably due to better preserved residual left ventricular function.
More Related Videos
05:26Postconditioning with Lactate-enriched Blood for Cardioprotection in ST-segment Elevation Myocardial Infarction
Published on: May 28, 2019
14:35Post-Myocardial Infarction Heart Failure in Closed-chest Coronary Occlusion/Reperfusion Model in Göttingen Minipigs and Landrace Pigs
Published on: April 17, 2021
Related Concept Videos
Acute Coronary Syndrome I: Introduction
Acute Coronary Syndrome III: Diagnostic Studies
Peripheral Artery Disease III: Interprofessional Care
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care